| Dr Amanda Nicole Hopkins, MD | |
|
3104 Blue Lake Dr Ste 110, Vestavia, AL 35243-2372 | |
| (205) 977-1949 | |
| (205) 977-1933 |
| Full Name | Dr Amanda Nicole Hopkins |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 11 Years |
| Location | 3104 Blue Lake Dr Ste 110, Vestavia, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962821108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LC0200X | Anesthesiology - Critical Care Medicine | MD.38349 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shelby Baptist Medical Center | Alabaster, AL | Hospital |
| Princeton Baptist Medical Center | Birmingham, AL | Hospital |
| Brookwood Baptist Medical Center | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiologists Associated Pc | 6204739519 | 361 |
News Archive
The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans.
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis. Many of these people take over-the-counter anti-inflammatory medications that block production of certain molecules, known as bioactive lipids, to reduce pain and swelling. Yet, the role of these lipids is not yet understood completely, and medications may have adverse side effects.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics.
› Verified 4 days ago
| Entity Name | Anesthesiologists Associated Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285140921 PECOS PAC ID: 6204739519 Enrollment ID: O20180502000003 |
News Archive
The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans.
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis. Many of these people take over-the-counter anti-inflammatory medications that block production of certain molecules, known as bioactive lipids, to reduce pain and swelling. Yet, the role of these lipids is not yet understood completely, and medications may have adverse side effects.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics.
› Verified 4 days ago
| Entity Name | Anesthesiologists Associated Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396353280 PECOS PAC ID: 6204739519 Enrollment ID: O20200825003744 |
News Archive
The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans.
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis. Many of these people take over-the-counter anti-inflammatory medications that block production of certain molecules, known as bioactive lipids, to reduce pain and swelling. Yet, the role of these lipids is not yet understood completely, and medications may have adverse side effects.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Nicole Hopkins, MD 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243-2372 Ph: (205) 977-1949 | Dr Amanda Nicole Hopkins, MD 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243-2372 Ph: (205) 977-1949 |
News Archive
The European Commission supports the TransGeno project of UT researchers with 2.5 million euros. This support helps to recruit top researchers to work at the ERA Chair of Translational Genomics of the University of Tartu soon to be created. The research work done at the new chair will advance research in translational genomics, so that in the future, doctors would be able to diagnose diseases as early as possible, thus improving opportunities for treatment.
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans.
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis. Many of these people take over-the-counter anti-inflammatory medications that block production of certain molecules, known as bioactive lipids, to reduce pain and swelling. Yet, the role of these lipids is not yet understood completely, and medications may have adverse side effects.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
PAML announced today that the laboratory has entered into a collaborative agreement with Axela, Inc. to develop multiplex assays focused on immune status for vaccine preventable diseases. PAML is one of the nation's leading medical reference laboratories, and Axela focuses on multiplexed nucleic acid and protein analysis for clinical diagnostics.
› Verified 4 days ago
Joshua Morgan Varner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 | |
Philip Conger Johnson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 | |
Dr. Erin Dodd Morella, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2868 Acton Rd, Vestavia, AL 35243 Phone: 205-332-3160 Fax: 866-702-0880 | |
Mr. James Albert Brock Iii, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 | |
Sarah Gilmore Weaver, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 | |
Travis Davis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 | |
Michael Francis Narveson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3104 Blue Lake Dr Ste 110, Vestavia, AL 35243 Phone: 205-977-1949 |